Bertrand Lellouche started as CFO EU / US Financial Operations in October 2018 and has been promoted Group CFO in February 2020
Bertrand has more than 15 years’ experience as CFO & executive advisor for fast growing biotech companies, such as Eligo Bioscience, Step Pharma and Enterome, since 2015. He developed his financial, operational & strategic expertise through complex missions.
Previously he served as Group Finance Director at Prunay, a fast and innovative growing leader of 1500 employees, where he developed, structured and consolidated financial departments. He was also in charge of Prunay Services, the shared services group he created.
From 2001 to 2011, he has operated as VP-CFO within fast growing innovative groups, such as Tc Land, SpineGuard, NetASQ and Theradiag, preparing and leading them to IPO or acquisition. He started his career with Technomed, Coflexip (Technip) and Vivendi (Veolia), holding financial executive positions and participating in their large developments, including IPOs and M&A operations.
Bertrand obtained his MSc in International Management from the MBA Institute.